The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: Comparison with the National Cancer Institute-Common Toxicity Scale

Journal of the Peripheral Nervous System

Volumn 12, Issue 3, 2007, Pages 210-215

  Cavaletti, Guido ^a   Frigeni, Barbara ^a   Lanzani, Francesca ^a   Piatti, Marialuisa ^b   Rota, Stefania ^a   Briani, Chiara ^c   Zara, Gabriella ^c   Plasmati, Rosaria ^d   Pastorelli, Francesca ^d   Caraceni, Augusto ^e   Pace, Andrea ^f   Manicone, Mariagrazia ^g   Lissoni, Andrea ^a   Colombo, Nicoletta ^a,h   Bianchi, Giulia ^e   Zanna, Claudio ⁱ  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Clinica Neurologica AO S Gerardo   (Italy)

^c Dipartimento di Neuroscienze   (Italy)

^d BELLARIA HOSPITAL   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^g UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^h EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

ⁱ Sigma Tau ifr   (Italy)

Author keywords

Chemotherapy induced peripheral neuropathy; Total Neuropathy Score

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; THALIDOMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SENSITIVITY ANALYSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; NEOPLASMS; NEUROLOGIC EXAMINATION; PERIPHERAL NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES;

EID: 34548637553     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2007.00141.x     Document Type: Article

References (15)

1. Bianchi G, Vitali G, Caraceni A, Ravaglia S, Capri G, Cundari S, Zanna C, Gianni L (2005). Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur J Cancer 41: 1746 1750.
2. Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Parma G, Lissoni A, Fei F, Cundari S, Zanna C (2003). Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale. Neurology 61: 1297 1300.
3. Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Franchi D, La Presa MT, Lissoni A, Buda A, Fei F, Cundari S, Zanna C (2004). Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. Ann Oncol 15: 1439 1442.
4. Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C, Cocito D, Padua L, Ghiglione E, Manicone M, Giussani G (2006). Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst 11: 135 141.
5. Chaudhry V, Chaudhry M, Crawford TO, Simmons-O'Brien E, Griffin JW (2003). Toxic neuropathy in patients with pre-existing neuropathy. Neurology 60: 337 340.
6. Cornblath DR, Chaudhry V, Carter K, Lee D, Seysedadr M, Miernicki M, Joh T (1999). Total neuropathy score: validation and reliability study. Neurology 53: 1660 1664.
7. Dubois D, Dhawan R, van de Velde H, Esseltine D, Gupta S, Viala M, de la Loge C (2006). Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. J Clin Oncol 24: 976 982.
8. Forman AD (2004). Peripheral neuropathy and cancer. Curr Oncol Rep 6: 20 25.
9. Padua L, Schenone A, Aprile I, Benedetti L, Caliandro P, Tonali P, Orazio EN (2005). Quality of life and disability assessment in neuropathy: a multicentre study. J Peripher Nerv Syst 10: 3 10.
10. Postma TJ, Heimans JJ (2000). Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol 11: 509 513.
11. Postma TJ, Heimans JJ, Muller MJ, Ossenkoppele GJ, Vermorken JB, Aaronson NK (1998). Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol 9: 739 744.
12. Quasthoff S, Hartung HP (2002). Chemotherapy-induced peripheral neuropathy. J Neurol 249: 9 17.
13. Umapathi T, Chaudhry V (2005). Toxic neuropathy. Curr Opin Neurol 18: 574 580.
14. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003). Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63: 1549 1563.
15. Visovsky C (2003). Chemotherapy-induced peripheral neuropathy. Cancer Invest 21: 439 451.